Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma | |
Sun, Si; Yu, Hui; Wang, Huijie; Zhang, Hai; Wu, Xianghua; Wang, Jialei; Chang, Jianhua | |
刊名 | ONCOLOGY RESEARCH AND TREATMENT
![]() |
2019 | |
卷号 | 42期号:3 |
关键词 | Esophageal cancer Chemotherapy Metastatic Squamous cell cancer, SCC |
ISSN号 | 2296-5270 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3595321 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Sun, Si,Yu, Hui,Wang, Huijie,et al. Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma[J]. ONCOLOGY RESEARCH AND TREATMENT,2019,42(3). |
APA | Sun, Si.,Yu, Hui.,Wang, Huijie.,Zhang, Hai.,Wu, Xianghua.,...&Chang, Jianhua.(2019).Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma.ONCOLOGY RESEARCH AND TREATMENT,42(3). |
MLA | Sun, Si,et al."Phase II Study of S-1 plus Cisplatin as First-Line Therapy in Patients with Metastatic Esophageal Carcinoma".ONCOLOGY RESEARCH AND TREATMENT 42.3(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论